VSee Health, Inc.
VSEED Healthcare Health Information Services
In the quarter to June 2026, revenue grew 48.0%, EPS grew 106.3%, free cash flow fell 257.6% and total debt rose 31.6%, each against the same quarter a year earlier.
Follow VSEED
VSee Health, Inc. (VSEED) EV/Sales
As of 16 October 2026, VSee Health, Inc. (VSEED) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from −0.3× (March 2026) to 0.2× (September 2026); the current reading is higher than 99% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −0.3× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | −0.3× | — |
| Sep 2025 | 0.0× | (70.40%) |
| 9 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ACON Aclarion, Inc. compare | −137× |
| HLTHQ Cue Health Inc. compare | −1.1× |
| ZCMD Zhongchao Inc. compare | −0.4× |
| WORX SCWorx Corp. compare | −0.3× |
| LGMK LogicMark, Inc. compare | −0.1× |
| MNDR Mobile-health Network Solutions compare | n/m |
| VSEED VSee Health, Inc. | 0.2× |
| MGRX Mangoceuticals, Inc. compare | 15.6× |
| MSPR MSP Recovery, Inc. compare | 27.0× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)